Cytosolix, Inc is a startup based in the United States, most recent round Seed, 1 tracked investor.
Based in the United States, Cytosolix, Inc is a startup. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Develops weakly-acidic derivatives of existing small-molecule oncology drugs that selectively target the acidic tumor microenvironment to improve tumor selectivity and widen therapeutic windows. The company's Tumor Activated Permeability (TAP) platform chemically redesigns drugs to concentrate activity in solid tumors and reduce dose-limiting toxicities.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.